TABLE 5.
Repeated-measures multivariate ANOVA (RM-MANOVA) testing for effects of current plasma docosahexaenoic acid (DHA) concentrations on event-related potential variables1
Low current DHA concentration (n = 75) |
High current DHA concentration (n = 76) |
||||
Component | New | Old | New | Old | P for DHA |
FN400 latency (ms) | 399.7 ± 49.8 | 401.0 ± 45.6 | 387.5 ± 43.2 | 394.6 ± 40.9 | 0.11 |
FN400 amplitude (μV) | −10.2 ± 6.2 | −7.7 ± 6.6 | −11.8 ± 6.7 | −9.2 ± 6.7 | 0.04 |
LPC amplitude (μV) | 11.3 ± 7.0 | 14.6 ± 7.2 | 12.1 ± 6.7 | 15.4 ± 7.0 | 0.34 |
All values are means ± SDs for latencies and amplitudes for FN400 [300–500 ms, midline frontal electrode (Fz)] and the late positive component [LPC; 500–800 ms, midline parietal electrode (Pz)]. F-ratio P values are from RM-MANOVA with condition (old or new) as the within-subject factor and the DHA group (split at the median) as the between-subjects factor. No condition × DHA interaction effect was significant (all P > 0.20). Covariates included in the RM-MANOVA models were the same as listed in Table 4.